WealthchartX

Crypto Analysis BTC/USD Market Update: 17% Crash, $60K Battle & What Comes Next Bitcoin has shed over 51% from its all-time high and is testing a critical support zone. Here's a full breakdown of the current setup, the forces driving the decline, and key levels traders must watch. 📅 June 7, 2026 | ⏱ 6 min read | WealthChartX 📊 Live Snapshot — June 7, 2026 Current Price ~$60,700 7-Day Change −17% From ATH ($126,080) −51.7% 24H Range $59,496 – $61,464 24H Volume ~$15.8B Market Cap ~$1.21T The Big Picture: Where Bitcoin Stands Right Now Bitcoin is at an inflection point. After touching an all-time high of $126,080 earlier in the cycle, BTC/USD has since entere...

  Deep Dive · Travel & OTA Sector EasyMyTrip (EASEMYTRIP): India's 2nd Largest OTA Is Losing Its Edge — Here's What the Numbers Say From 63% ROCE to near-zero in four years. From India's fastest-growing travel portal to its first-ever annual net loss. A data-driven breakdown of what went wrong — and whether a recovery is possible. ₹6.74 CMP (05 Jun) -39% 1-Year Return ₹2,686 Cr Market Cap -₹48 Cr FY26 Net Profit WealthChartX Verdict EasyMyTrip is a structurally challenged business going through a painful margin reset. The stock has corrected 39% in a year and trades at ~3× book despite a loss year. We are watchlist-only at current levels — the data does not yet support a buy thesis. This article explains why. 1. The Business: What EasyMyTrip Actually...

Stock Analysis · Small Cap Pharma Kwality Pharmaceuticals: 100% Rally & Still Running? A deep dive into NSE's buzzing small-cap pharma play — valuations, risks & what to do now WealthChartX · May 2026 · 5 min read CMP ~₹1,720 Kwality Pharmaceuticals has been one of the more electrifying small-cap stories of the past year — doubling in price while most of the market played cautious. But with fresh all-time highs and a premium valuation, the question every investor is asking is: is this a hold, a buy, or time to step back? ~100%+ 1-Year Return 30–40x P/E Ratio ₹1,700–1,780 Recent ATH Zone The Bull Case — What's Driving the Rally Kwality Pharma's rise isn't just a momentum trade. The fundamentals have genuinely improved. Revenue and profit have jumped sharply over the last few quarters, driven largely by a growing pharma export book. With India's pharma sector gaining global momentum — particularly in generic formulations for regulated markets — Kwality appears...

Premier Energies Q4 FY26 Results — Is This Solar Stock a Buy at ₹981? Q4 FY26 Results · Solar Sector Premier Energies: Strong Profit Growth — Is This Solar Stock a Buy at ₹981? India's clean energy boom powers another quarter of exceptional returns CMP ₹981.60 NSE · Live Net Profit ₹456.84 Cr Q4 FY26 Profit Growth +64.44% Year-on-year Quarterly Sales ₹2,230 Cr Q4 FY26 Sales Growth +37.60% Year-on-year A Quarter That Turned Heads Premier Energies has delivered one of its most compelling quarterly performances to date, posting a net profit of ₹456.84 crore — a striking 64.44% jump over the same period last year. Revenue from operations climbed 37.60% year-on-year to ₹2,230.30 crore, unde...

◆   Stock Analysis   ◆   Indian Markets   ◆   Q4 FY26 Results Season   ◆ Q4 FY26 Results Bharat Wire Ropes: Profit Surges 38.7% Quarter-on-Quarter A strong recovery story — but is the momentum built to last? Here's the complete breakdown. By WealthChartX Desk  |  May 17, 2026  |  5 min read 📊 Q4 FY26 — At a Glance Net Profit ₹20.65 Cr ▲ 38.7% QoQ ▼ 4.8% YoY Operating Income ₹31.35 Cr ▲ 33.4% QoQ Revenue ~₹172 Cr ▲ Improved QoQ Profit Before Tax ₹27.91 Cr ▲ 39% QoQ Bharat Wire Ropes Limited (BWR) has delivered a notably stronger fourth quarter for FY26, posting a...